A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
Status:
Recruiting
Trial end date:
2029-02-23
Target enrollment:
Participant gender:
Summary
Evaluating the efficacy and safety of adebrelimab in combination with apatinib, gemcitabine
and cisplatin in the neoadjuvant treatment of patients with biliary tract malignancies.
Phase:
Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University